Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria

Smolen, JS; Aletaha, D; Gruben, D; Zwillich, SH; Krishnaswami, S; Mebus, C

Smolen, JS (reprint author), Med Univ Vienna, Dept Med 3, Div Rheumatol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

ARTHRITIS & RHEUMATOLOGY, 2017; 69 (4): 728

Abstract

Objective. Tofacitinib is an oral JAK inhibitor that is used for the treatment of rheumatoid arthritis (RA). In previous clinical trials of tofacitini......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索